NASDAQ: LBPH - Longboard Pharmaceuticals, Inc.

छह महीने के लिए लाभप्रदता: +1.52%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Longboard Pharmaceuticals, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352, which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc.

अधिक जानकारी
to develop and commercialize LP352, LP659, LP143, and other compounds. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2021-03-12
ISIN US54300N1037
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.longboardpharma.com
Цена ао 59.98
प्रति दिन मूल्य परिवर्तन: 0% (59.98)
प्रति सप्ताह मूल्य परिवर्तन: 0% (59.98)
प्रति माह मूल्य परिवर्तन: 0% (59.98)
3 महीने में कीमत में बदलाव: 0% (59.98)
छह महीने में कीमत में बदलाव: +1.52% (59.08)
प्रति वर्ष मूल्य परिवर्तन: +212.4% (19.2)
3 वर्षों में मूल्य परिवर्तन: +1 078.39% (5.09)
वर्ष की शुरुआत से मूल्य परिवर्तन: 0% (59.98)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0 0
P/BV 3.44 5
P/E 0 0
EV/EBITDA -2.24 0
कुल: 3.13

क्षमता

नाम अर्थ श्रेणी
ROA, % -107.35 0
ROE, % -132.99 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.0084 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 0 0
लाभप्रदता Ebitda, % 294.13 10
लाभप्रदता EPS, % 181.33 10
कुल: 8
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Cormorant Asset Management, LP 2353141 7
FMR, LLC 1649503 4.91
Price (T.Rowe) Associates Inc 1626982 4.84
Farallon Capital Management Llc 1560500 4.64
Polar Capital Holdings PLC 1000000 2.98
Ikarian Capital, LLC 979462 2.91
Integral Health Asset Management, LLC 900000 2.68
Blackrock Inc. 869879 2.59
Point72 Asset Management, L.P. 825000 2.45
Vanguard Group Inc 786433 2.34

ETFशेयर करना, %वर्ष के लिए लाभप्रदता, %लाभांश, %
iShares Morningstar Small-Cap Value ETF 0.02069 189.23 2.50476
iShares Morningstar Small-Cap ETF 0.01851 391.25 1.60498
iShares Morningstar Small-Cap Growth ETF 0.01676 596.94 0.72598
0.02392.471.61



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Kevin R. Lind President, CEO, Secretary & Director 1.07M 1976 (49 साल)
Ms. Brandi L. Roberts CPA, M.B.A. Executive VP & CFO 662.65k 1974 (51 वर्ष)
Dr. Randall E. Kaye M.D. Executive VP & Chief Medical Officer 717.95k 1962 (63 वर्ष)
Mr. Chadwick J. Orevillo MPH Executive VP & Head of Operations N/A
Mr. Steven W. Spector J.D. Executive VP, Head of Business Development & General Counsel N/A 1965 (60 साल)
Dr. Anne M. Danks Ph.D. VP & Head of Nonclinical Research & Development N/A
Mr. Gus Cardenas VP & Head of Quality Assurance N/A
Dr. Marco Peters Ph.D. VP & Head of Translational Science N/A
Dr. Dewey McLin Ph.D. VP & Head of Medical Affairs N/A
Ms. Megan E. Knight VP & Head of Investor Relations

पता: United States, La Jolla. CA, 4275 Executive Square - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.longboardpharma.com